App1: An Antiphagocytic Protein That Binds

Del PoetaMorace, Chiara Luberto, Stephen Tomlinson and MaurizioS. Cymbalyuk, Asfia Qureshi, Yuxiang Huang, Giulia Paola Stano, Virginia Williams, Maristella Villani, Eugenehttp://www.jimmunol.org/content/182/1/84J Immunol€2009; 182:84-91; ;Referenceshttp://www.jimmunol.org/content/182/1/84.full#ref-list-1This article cites 42 articles, 15 of which you can access for free at: Subscriptionshttp://jimmunol.org/subscriptionsInformation about subscribing to The Journal of Immunology is online at: Permissionshttp://www.aai.org/ji/copyright.htmlSubmit copyright permission requests at: Email Alertshttp://jimmunol.org/cgi/alerts/etocReceive free email-alerts when new articles cite this article. Sign up at:

[1]  Rengasamy Asokan,et al.  Mutational analysis of the complement receptor type 2 (CR2/CD21)-C3d interaction reveals a putative charged SCR1 binding site for C3d. , 2005, Journal of molecular biology.

[2]  M. Carroll,et al.  The role of complement in B cell activation and tolerance. , 2000, Advances in immunology.

[3]  J. Hatzfeld,et al.  Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line. , 1988, Journal of immunology.

[4]  V. Michael Holers,et al.  Structure of Complement Receptor 2 in Complex with Its C3d Ligand , 2001, Science.

[5]  V. Vetvicka,et al.  Regulation of CR3 (CD11b/CD18)‐dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules , 1999, Clinical and experimental immunology.

[6]  Katia Perruccio,et al.  The exploitation of distinct recognition receptors in dendritic cells determines the full range of host immune relationships with Candida albicans. , 2004, International immunology.

[7]  M. Hennig,et al.  Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans. , 2006, The Journal of clinical investigation.

[8]  D. Fearon,et al.  The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. , 1995, Annual review of immunology.

[9]  Ziya Kaya,et al.  Contribution of the innate immune system to autoimmune myocarditis: a role for complement , 2001, Nature Immunology.

[10]  C. Forsyth,et al.  Interaction of the fungal pathogen Candida albicans with integrin CD11b/CD18: recognition by the I domain is modulated by the lectin-like domain and the CD18 subunit. , 1998, Journal of immunology.

[11]  S. Levitz,et al.  Receptor-mediated recognition of Cryptococcus neoformans. , 2002, Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology.

[12]  Ziya Kaya,et al.  Complement receptors regulate lipopolysaccharide‐induced T‐cell stimulation , 2005, Immunology.

[13]  Arturo Casadevall,et al.  Vesicular Polysaccharide Export in Cryptococcus neoformans Is a Eukaryotic Solution to the Problem of Fungal Trans-Cell Wall Transport , 2006, Eukaryotic Cell.

[14]  S. Levitz,et al.  Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin. , 1991, The Journal of clinical investigation.

[15]  J. Murphy,et al.  Cryptococcal polysaccharides bind to CD18 on human neutrophils , 1997, Infection and immunity.

[16]  T. Kozel,et al.  Activation of the complement system by pathogenic fungi , 1996, Clinical microbiology reviews.

[17]  Juneann W Murphy,et al.  Immunological down‐regulation of host defenses in fungal infections , 1999, Mycoses.

[18]  J. Ahearn,et al.  Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. , 1996, Immunity.

[19]  A. Casadevall,et al.  Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute? , 1998, Medical mycology.

[20]  Anna Erdei,et al.  Regulation of B-cell activation by complement receptors CD21 and CD35. , 2003, Current pharmaceutical design.

[21]  M. Walport,et al.  Complement. Second of two parts. , 2001, The New England journal of medicine.

[22]  H. Kozono,et al.  Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. , 1988, Journal of immunology.

[23]  Arturo Casadevall,et al.  Antibody Interactions with the Capsule ofCryptococcus neoformans , 2000, Infection and Immunity.

[24]  M. Walport.  Complement. First of two parts. , 2001, The New England journal of medicine.

[25]  John R Perfect,et al.  Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans. , 2003, The Journal of clinical investigation.

[26]  Liangji Zhou,et al.  The CD19/CD21 signal transduction complex of B lymphocytes. , 1994, Immunology today.

[27]  T. Schulz,et al.  Structural and functional relationships among receptors and regulators of the complement system. , 1988, Molecular immunology.

[28]  Arturo Casadevall,et al.  CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. , 2002, Immunity.

[29]  M. Carroll,et al.  The complement system in B cell regulation. , 2004, Molecular immunology.

[30]  H. E. Gilbert,et al.  Solution structure of the complex between CR2 SCR 1-2 and C3d of human complement: an X-ray scattering and sedimentation modelling study. , 2005, Journal of molecular biology.

[31]  T. Mayadas,et al.  Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan. , 2000, Immunopharmacology.

[32]  V. Holers,et al.  Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. , 1998, Journal of immunology.

[33]  Maria Teresa Montagna,et al.  APP1 Transcription Is Regulated by Inositol-phosphorylceramide Synthase 1-Diacylglycerol Pathway and Is Controlled by ATF2 Transcription Factor in Cryptococcus neoformans* , 2005, Journal of Biological Chemistry.

[34]  Francesco Bistoni,et al.  Adaptation of Candida albicans to the host environment: the role of morphogenesis in virulence and survival in mammalian hosts. , 2003, Current opinion in microbiology.

[35]  R. Karr,et al.  Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[36]  D. Isenman,et al.  Structure-Guided Identification of C3d Residues Essential for Its Binding to Complement Receptor 2 (CD21)1 , 2000, The Journal of Immunology.

[37]  A. Vecchiarelli,et al.  Immunoregulation by capsular components of Cryptococcus neoformans. , 2000, Medical mycology.

[38]  B. Klein,et al.  The WI-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14. , 1995, Journal of immunology.

[39]  Fabrice Chrétien,et al.  Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. , 2002, The Journal of infectious diseases.

[40]  G. Bancroft,et al.  CR3‐dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement‐opsonized Cryptococcus neoformans , 1997, Immunology.

[41]  Asfia Qureshi,et al.  Stimulatory Effect of Diacylglycerol : Cryptococcus Neoformans Promoter in Atf2 Transcription Factor Binds to the App1 , 2007 .